Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
18/04/2026
The White House: Discussed partnership opportunities with the CEO of Anthropic, as well as the challenges faced in scaling up the application of this technology.
Latest
7 m ago
Trump boasts about falling oil prices.
22 m ago
Meta paid $15.6 billion to Broadcom last year.
24 m ago
American Airlines has expressed no intention to merge with United Airlines.
26 m ago
As of Friday's closing, Kailera Therapeutics soared 62.5% on its first day of trading, reaching a market value of $3 billion. The company, founded in 2024, is developing four GLP-1-based weight-loss drugs, including an GLP-1/GIP dual receptor agonist injection HRS9531 licensed from Chinese partner Hengrui Medicine. The prospectus shows that Bain Capital and Hengrui Medicine are both shareholders with more than 5% stake in Kailera.
28 m ago
Alamar Biosciences, a company specializing in the production of medical devices for detecting protein biomarkers to diagnose diseases, saw its shares rise by 29.41% on its first day of trading on the US stock market on Friday. The company's devices can detect and quantify over 100 protein biomarkers in a single sample with a minimum volume of only 10 microliters of biological fluid. According to the prospectus, the company's largest shareholder is Chinese venture capital firm Qiming Venture.
See all latest